Wall Street Analysts Believe Keros Therapeutics (KROS) Could Rally 153.67%: Here's is How to Trade

Keros Therapeutics, Inc. (KROS) closed the last trading session at $11.59, gaining 5.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 29.40 indicates a 153.7% upside potential.The average comprises 10 short-term price targets ranging from a low of $15 to a high of$ 43, with a standard deviation of $10.46. While the lowest estimate indicates an increase of 29.4% from the current ...